drugset / Trial / NCT00452296

Tight Glycemic Control in Acute Exacerbations of COPD

NCT00452296

Unknown 84 enrolled Soroka University Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

Glucose control has been shown as an important and independent prognostic factor in several acute conditions in hospitalized patients, including Acute MI, stroke, cardiac surgery and in critical care units. Patients with acute exacerbation of COPD (AECOPD)and diabetes treated with insulin had a longer in-patient stay and more frequent isolation of Gram negative bacteria from sputum than those without diabetes.Hyperglycemia (\>11 mmol/l) on admission predicted failure of non-invasive ventilation and infectious pulmonary complications in patients admitted to the ICU with acute respiratory failure caused by severe AECOPD. The primary goal of this study is to test the hypothesis that in AECOPD, tight glycemic control during hospital stay will improve outcome of hospitalization. The secondary goal of this study is to test new ways in controlling patients in the internal medicine ward.

Timeline

Start
2007-04
Primary completion
2010-05
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic